Pfizer/BioNTech say Omicron-based COVID shots improve response vs that variant (Reuters)

Reuters
Pfizer/BioNTech say Omicron-based COVID shots improve response vs that variant – Pfizer Inc and BioNTech SE said on Saturday that a booster dose of updated versions of their COVID-19 vaccine, modified specifically to combat the Omicron coronavirus variant, generated a higher immune response against that variant. …

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter